Cart
sales@molnova.com
(2S,3S)-3-Hydroxy-2-methyl-3-phenylpropanoic acid
CAS No. 76549-02-5
(2S,3S)-3-Hydroxy-2-methyl-3-phenylpropanoic acid( —— )
Catalog No. M35333 CAS No. 76549-02-5
(2S,3S)-3-Hydroxy-2-methyl-3-phenylpropanoic acid is a chemical synthesis intermediate.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 255 | In Stock |
|
| 10MG | 375 | In Stock |
|
| 25MG | 562 | In Stock |
|
| 50MG | 770 | In Stock |
|
| 100MG | 1051 | In Stock |
|
| 200MG | 1414 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name(2S,3S)-3-Hydroxy-2-methyl-3-phenylpropanoic acid
-
NoteResearch use only, not for human use.
-
Brief Description(2S,3S)-3-Hydroxy-2-methyl-3-phenylpropanoic acid is a chemical synthesis intermediate.
-
Description(2S,3S)-3-Hydroxy-2-methyl-3-phenylpropanoic acid is a chemical synthesis intermediate.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number76549-02-5
-
Formula Weight180.2
-
Molecular FormulaC10H12O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES[C@@H]([C@@H](C(O)=O)C)(O)C1=CC=CC=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
(D-Arg1,D-Trp7·9,Leu...
Spantide I, a substance P analog, is a selective NK1 receptor antagonist, with Ki values of 230 nM and 8150 nM for NK1 and NK2 receptor, respectively. Spantide I provides an approach to reduce type 1 and enhance the type 2 cytokine IL-10 in the infected cornea, leading to a significant reduction in corneal perforation.
-
EMD638683
EMD638683a novel SGK inhibitor with antihypertensive potency(with an IC50 of 3 μM).
-
Gatipotuzumab
Gatipotuzumab (PankoMab) is a novel humanized monoclonal antibody conjugated to the tumor-associated epitope of mucin 1 (TA-MUC1) with potential anti-tumor activity for the study of recurrent epithelial ovarian cancer.
